Correlation Between Arrowhead Pharma and Brickell Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharma and Brickell Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharma and Brickell Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharma and Brickell Biotech, you can compare the effects of market volatilities on Arrowhead Pharma and Brickell Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharma with a short position of Brickell Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharma and Brickell Biotech.

Diversification Opportunities for Arrowhead Pharma and Brickell Biotech

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arrowhead and Brickell is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharma and Brickell Biotech Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brickell Biotech and Arrowhead Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharma are associated (or correlated) with Brickell Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brickell Biotech has no effect on the direction of Arrowhead Pharma i.e., Arrowhead Pharma and Brickell Biotech go up and down completely randomly.

Pair Corralation between Arrowhead Pharma and Brickell Biotech

Given the investment horizon of 90 days Arrowhead Pharma is expected to generate 0.82 times more return on investment than Brickell Biotech. However, Arrowhead Pharma is 1.22 times less risky than Brickell Biotech. It trades about -0.19 of its potential returns per unit of risk. Brickell Biotech is currently generating about -0.38 per unit of risk. If you would invest  3,942  in Arrowhead Pharma on July 4, 2022 and sell it today you would lose (637.00)  from holding Arrowhead Pharma or give up 16.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy59.09%
ValuesDaily Returns

Arrowhead Pharma  vs.  Brickell Biotech Inc

 Performance (%) 
       Timeline  
Arrowhead Pharma 
Arrowhead Performance
0 of 100
Over the last 90 days Arrowhead Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2022. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Brickell Biotech 
Brickell Performance
0 of 100
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Arrowhead Pharma and Brickell Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arrowhead Pharma and Brickell Biotech

The main advantage of trading using opposite Arrowhead Pharma and Brickell Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharma position performs unexpectedly, Brickell Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will offset losses from the drop in Brickell Biotech's long position.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Arrowhead Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Arrowhead Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Arrowhead Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Arrowhead Pharma.
The idea behind Arrowhead Pharma and Brickell Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Brickell Biotech vs. Microsoft Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go